Recent

% | $
Quotes you view appear here for quick access.

MELA Sciences, Inc. Message Board

  • e11ndofwar e11ndofwar Oct 18, 2012 9:22 AM Flag

    a winding spring

    While I am not a chartist, one that I do follow shows an enormous amount of resistance at the $3.24 level. We have been trading in a very tight band for months now and it is like watching a spring being steadily tightened. Beyond the $3.24 level, there is very little resistance to the top of the chart at $4.70.
    While this trading range has been frustrating, it does provide a long term investor who is doing proper due dilligence with an increasingly interesting investment opportunity. Look at this message board. When we set aside the #$%$. postings, you can see an acceleration of placements nationally. We know that, the market is as yet unaware. I continue to add to my position.
    regards endo

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • samhasson@sbcglobal.net samhasson Oct 18, 2012 9:50 AM Flag

      Endo, I've been waiting for you to post so I can ask you something.

      Let me begin by saying how we all know that a frog slowly boiling in a pot of water will eventually die, whereas if the heat is on full blast, they will jump out of the pot real fast.

      Now to Mela and the stock market. If the roll out were fast and furious, then the stock would take off parabolically due to the excitment generated and then come down a little. But the pps would close higher than from where the take-off started. Here I am convinced the roll out is proceeding according to plan. But due to its rational and methodical nature, the market never gets excited or interested enough to get in on the ground floor, and the pps never increases significantly....at least for a long time.

      In this latter case maybe the price increase in stock will come once earnings are solid and on the rise. But that is down the road. As for new investors, if they know what they are doing, the best thing for them is to use options, or short term trading, both of which are really profitable most of the time. Institutional firms and the buy and hold crowd are going to wait for earnings, no matter what.

      I'm not using charts or ratios or any of that stuff. Just trying to see what is happening here with Mela. My basic assumption is that the tool is very effective, and the roll out is proceeding as projected. But what do you think? Also, any constructive thoughts on this question by others would also be appreciated. Sam

      Sentiment: Hold

      • 2 Replies to samhasson
      • Sam
        Years ago I invested heavily in the short term options market. I had some big wins and some awful losses. The only part of the options market I now participate in is either Leaps or longer term call options. Over the past couple of months I have extablished a position in April $3,00 calls. At the moment I am underwater but have 6 months left on the options. I totally agree with several investors here who have written that the current price of MELA is low enough that you don't have to take on the time risk of options. For folks not up to speed on options, investing in the stock is the smarter move. 90% of my MELA investment is stock, with my options position only accounting for 10%. Not sure if this is the input you were seeking.
        regards endo

      • "Now to Mela and the stock market. If the roll out were fast and furious, then the stock would take off parabolically due to the excitment generated and then come down a little. But the pps would close higher than from where the take-off started. Here I am convinced the roll out is proceeding according to plan. But due to its rational and methodical nature, the market never gets excited or interested enough to get in on the ground floor, and the pps never increases significantly....at least for a long time."

        We know what Dr Gulfo is capable of Sam with the way he competently out maneuvered the FDA. The man could someday write the book on that one. As he has stated in his CCs, they appear to have passed the learning phase in field application and are now going for the 275 with gusto. Derm acceptance appears to be taking off and I believe that Gulfo will once again come out on top at the end of Q1 2013.

 
MELA
1.56+0.02(+1.30%)May 27 4:00 PMEDT